March 2026
The global glioblastoma multiforme treatment market size was estimated at USD 3.01 billion in 2025 and is expected to hit around USD 6.48 billion by 2035, growing at a CAGR of 7.97%
September 2026
The US glioblastoma multiforme treatment market reached USD 850.30 million in 2026, featuring leading US glioblastoma multiforme treatment market companies such as Amgen, Inc., Pfizer Inc., Arbor Pharmaceuticals, LLC.
September 2026
The global psoriasis treatment market size is expected to increase from USD 36.87 billion in 2026 and is projected to hit around USD 73.04 billion by 2035, with a CAGR of 7.9%.
September 2026
The global non-invasive aesthetic treatment market is evaluated at USD 24.45 billion in 2026 and is predicted to hit around USD 43.75 billion by 2035, at a CAGR of 6.8%.
September 2026
The asthma treatment market size accounted for USD 29.56 billion in 2026 and is expected to hit around USD 36.8 billion by 2035, poised to grow at a CAGR of 2.42%.
September 2026
The global post-traumatic stress disorder treatment market size is projected to hit around USD 3.55 billion by 2035 from USD 2.47 billion in 2026, with a CAGR of 4.12%.
September 2026
The global acne treatment market size was valued at USD 12.86 billion in 2026 and is expected to hit around USD 20.99 billion by 2035, growing at a CAGR of 5.60%.
September 2026
The global stomach cancer treatment market size is estimated to surpass around USD 19.42 billion by 2035 from USD 6.84 billion in 2026, with a solid CAGR of 12.31%.
September 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 3.05 billion in 2026, at a solid CAGR of 6.00%.
September 2026
The global dental fluoride treatment market size is valued at USD 19.97 billion in 2026 and is projected to hit around USD 44.06 billion by 2034 with a CAGR of 10.40%.
September 2026
The global postmenopausal osteoporosis treatment market size is calculated at USD 14.20 billion in 2026 and is projected to hit around USD 22.51 billion by 2035 with a CAGR of 5.26%.
September 2026
The global liver fibrosis treatment market size is estimated to hit around USD 57.11 billion by 2035 from USD 22.60 billion in 2026, with a solid CAGR of 10.87%.
September 2026
The global rosacea treatment market size is estimated at USD 2.43 billion in 2026 and is projected to surpass around USD 4.23 billion by 2034, with a solid CAGR of 7.14%.
September 2026
The global radiation treatment planning solutions market size was evaluated at USD 3.23 billion in 2026 and is predicted to hit around USD 6.53 billion by 2035, growing at a CAGR of 8.15%.
September 2026
The global varicose veins treatment market size was evaluated at USD 1.69 billion in 2026 and is predicted to hit around USD 2.96 billion by 2035, growing at a CAGR of 6.44%.
September 2026
The global intensive anti-aging treatment market size was evaluated at USD 32.07 billion in 2026 and is predicted to hit around USD 61.24 billion by 2035, growing at a CAGR of 7.45%.
September 2026
The global middle ear infections treatment market size is estimated to hit around USD 8.44 billion by 2035 increasing from USD 5.66 billion in 2026, with a CAGR of 4.55%.
September 2026
The tendonitis treatment market size was calculated at USD 249.63 billion in 2026 and is projected to hit around USD 340.22 billion by 2035 with a CAGR of 3.50%.
September 2026
The substance abuse treatment market size is expected to increase from USD 36.83 billion by 2034 from USD 17.23 billion in 2026 with a solid CAGR of 10.05%.
September 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 2.13 billion in 2026, with a CAGR of 7.12%.
September 2026
The ear nose throat (ENT) treatment market size was estimated to hit around USD 35.15 billion by 2035 increasing from USD 21.10 billion in 2026, with a CAGR of 5.82%.
September 2026
The respiratory antiviral treatment market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The global mouth ulcer treatment market size was calculated at USD 1.75 billion in 2026 and is expected to worth around USD 2.46 billion by 2035 with a CAGR of 3.89%.
September 2026
The global osteoporosis treatment market size is accounted at USD 14.10 billion in 2026 and is projected to hit around USD 21.79 billion by 2035 with a CAGR of 4.96%.
September 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 4.35 billion in 2026 with a CAGR of 15.48%.
September 2026
The global seed treatment market size is calculated at USD 19.65 billion in 2026 and is projected to hit around USD 42.02 billion by 2035 with a notable CAGR of 8.83%.
September 2026
The hemophilia treatment market was valued at USD 23.23 billion in 2026, with leading companies including Shire, CSL Behring, Grifols, S.A., Biogen Inc..
September 2026
The biological treatment technologies market was valued at USD 3.34 billion in 2026, with leading companies including Scarab International, Alfa Laval, Pentair PLC, Evoqua Water Technology.
September 2026
The global amblyopia treatment market size was valued at USD 4.37 billion in 2026 and is projected to attain around USD 5.88 billion by 2034 with a CAGR of 3.80%.
September 2026
The global addiction treatment market size was valued at USD 10.53 billion in 2026 and is expected to hit around USD 16.22 billion by 2034, growing at a CAGR of 5.56%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com